FRANKFURT (Reuters) - Fresenius Medical Care, the dialysis specialist controlled by Fresenius SE, reported its second-quarter net profit jumped 11 percent to $289 million, beating average expectations.
The world’s largest operator of clinics and maker of dialysis machines said on Wednesday revenue growth in both North America and International was at a double digit percentage at constant currencies despite a difficult global economic environment.
Revenues rose 9 percent to $3.4 billion during the quarter, FMC said and affirmed its full-year sales and earnings outlook for net income of around $1.3 billion on revenue of around $14 billion.
Analysts in a Reuters poll had expect net income of $277 million and revenues of $4.47 billion.
Reporting by Harro ten Wolde